SAVR Vs Transfemoral TAVR: 1-Year Outcomes

Share on FacebookTweet about this on TwitterShare on LinkedIn

Study results suggest that surgical aortic valve replacement (SAVR) and transfemoral transcatheter aortic valve replacement (TAVR) appears to have comparable short-term outcomes. The all-cause mortality rate at 1 year was 13.8% for transfemoral TAVR and 13.6% for SAVR. Rates of death from any cause and major adverse cardiac and cerebrovascular events were 18.2% for transfemoral TAVR and 17.6% for SAVR. The incidence rates for cerebrovascular events and rehospitalization due to cardiac reasons and acute heart failure were also similar for both groups at 1 year.

Source: Journal of the American College of Cardiology, August 18, 2015.

Submit a Comment

Your email address will not be published. Required fields are marked *

16 + three =